| Profitability | 7/100 |
| Growth | 39/100 |
| Momentum | 40/100 |
| Quality | 45/100 |
| Earnings Quality | 38/100 |
| Balance Sheet | 44/100 |
| Value | 40/100 |
| Risk (safety) | 65/100 |
| Overall | 36.8/100 |
| Symbol | IS Score |
|---|---|
| HUM | 27 |
| CI | 61 |
| ELV | 57 |
| MOH | 30 |
| CVS | 52 |
| OSCR | 76 |
| CNC | 37 |
These two disagree — business quality 37, price structure 82 out of 100, so the price reads better than the business does. We publish the disagreement rather than resolving it: they answer different questions, and the gap between them is information, not an error.
| Trigger | Where it stands now | What it would mean |
|---|---|---|
| IS Score reaches 55 and holds two consecutive quarters | now 36.8 | would move us up one band |
| IS Score stops falling - one quarter higher than the prior | last four: 36 → 35 → 39 → 37 | the direction matters more than the level |
| Technical vote share back above 50% | now 100% | price structure no longer broken |
| Institutional holder count rises two quarters running | peak 1,004 → now 1,004 | fewer institutions willing to hold is our clearest warning |
This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.
| Quarter | Holders | 13F shares | Value | Reported own% |
|---|---|---|---|---|
| 2026 Q2 | 1,004 | 490.8M | $30.2B | 99.4% |
| 2026 Q1 | 867 | 474.4M | $15.0B | 96.1% |
| 2025 Q4 | 912 | 476.5M | $19.5B | 96.5% |
| 2025 Q3 | 849 | 459.5M | $16.1B | 93.0% |
| 2025 Q2 | 871 | 480.4M | $25.9B | 97.3% |
| 2025 Q1 | 899 | 486.3M | $29.2B | 98.5% |
| 2024 Q4 | 877 | 481.2M | $28.8B | 97.4% |
| 2024 Q3 | 880 | 494.5M | $36.9B | 100.1% |
| 2024 Q2 | 895 | 521.8M | $33.8B | 105.7% |
| 2024 Q1 | 930 | 518.3M | $38.6B | 105.0% |
| 2023 Q4 | 896 | 511.3M | $37.0B | 103.5% |
| 2023 Q3 | 820 | 507.3M | $34.2B | 102.7% |
| Insider | Role | Date | Type | Shares | Value | Post-Txn Owned |
|---|---|---|---|---|---|---|
| Carson Michael A | Group President, Medicare&Spec | 2026-10-15 | TAX W/H | 7,130 | $0.50M | 115,752 |
| Tyler Lauren M | director | 2026-09-30 | A-Award | 482 | — | 3,698 |
| Tanji Kenneth | director | 2026-09-30 | A-Award | 603 | — | 13,093 |
| Samuels Theodore R. Ii | director | 2026-09-30 | A-Award | 583 | — | 25,796 |
| Eppinger Frederick H | director | 2026-09-30 | A-Award | 864 | — | 370,402 |
| Coughlin Christopher J | director | 2026-09-30 | A-Award | 583 | — | 19,294 |
| Pienkos Theodore J | Corporate Controller & CAO | 2026-09-15 | TAX W/H | 1,092 | $0.08M | 28,751 |
| Koster Christopher | Secretary & General Counsel | 2026-08-26 | SELL | 56,500 | $3.78M | 248,854 |
| 6-mo decomposition (Form 4) | Txns | Shares | Value | Signal weight |
|---|---|---|---|---|
| S — Open-market sales | 3 | 184,103 | $12.1M | Counted |
| F — Tax withholding | 10 | 79,120 | $3.0M | None — compensation |
| P — Open-market purchases | 0 | 0 | $0 | Counted — none occurred |
| Filed | Filer | Shares registered | Est. proceeds |
|---|---|---|---|
| 2026-08-26 | Koster Christopher | 56,500 | $3.8M |
| 2026-08-26 | Burdick Kenneth A | 43,600 | $2.8M |
| 2026-08-18 | Koster Christopher | 47,603 | $3.1M |
| 2026-08-05 | Burdick Kenneth A | 100,000 | $6.8M |
| Trailing 12 mo | 9 filings | 409,974 | $25M |
| Filed | Form | Reporting person | % of class | Shares |
|---|---|---|---|---|
| 2026-04-29 | SCHEDULE 13G | Vanguard Capital Management | 7.30% | 35.9M sh |
| 2026-03-26 | SCHEDULE 13G/A | The Vanguard Group | — | exit/reporting change |
| 2026-02-13 | SCHEDULE 13G | AQR Capital Management Holdings, LLC | 6.47% | 31.8M sh |
| 2025-11-05 | SCHEDULE 13G/A | Abigail P. Johnson | 0.70% | 3.3M sh |
| Member | Chamber | Trade | Size band | Traded | Disclosed |
|---|---|---|---|---|---|
| Ro Khanna | House | SELL | $1,001 - $15,000 | 2026-09-04 | 2026-10-09 |
| Ro Khanna | House | SELL | $15,001 - $50,000 | 2026-08-10 | 2026-09-07 |
| Tim Moore | House | SELL | $100,001 - $250,000 | 2025-08-18 | 2025-09-04 |
| Manager | Shares | Value |
|---|---|---|
| Assenagon Asset Management S.A. | 4.1M | $254M |
| Ninety One Uk Ltd | 1.5M | $93M |
| Wealth Enhancement Advisory Servic | 644,499 | $38M |
| Wedge Capital Management L L P/Nc | 409,069 | $25M |
| Fjarde Ap-Fonden /Fourth Swedish N | 183,004 | $11M |
| Counterpoint Mutual Funds Llc | 145,297 | $9M |
| Fund | Weight | Position |
|---|---|---|
| VITSX | 0.0% | $973M |
| VTSAX | 0.0% | $973M |
| VSMPX | 0.0% | $973M |
| VTI | 0.0% | $973M |
| VOO | 0.0% | $806M |
| VFFSX | 0.0% | $806M |
| ATS Venue (4-wk) | Shares | Avg trade |
|---|---|---|
| Incr Intelligent Cross Llc | 6.3M | 62 sh |
| Ubsa Ubs Ats | 5.8M | 70 sh |
| Mstx Ms Trajectory Cross (Ats-1) | 5.0M | 91 sh |
| Sgmt Sigma X2 | 3.2M | 71 sh |
| Ebxl Level Ats | 3.2M | 37 sh |
| Mspl Ms Pool (Ats-4) | 2.8M | 192 sh |
Moat score 42/100 — Weak; primary source Efficient Scale.
| Officer | Title |
|---|---|
| Sarah London | Chief Executive Officer & Director |
| Keith Harvey Williamson | President of Charitable Foundation |
| Andrew Lynn Asher | Executive Vice President & Chief Financial Officer |
| Christopher Andrew Koster | Executive Vice President, General Counsel & Secretary |
| Period | EPS est. | EPS actual | EPS surprise | Rev est. ($M) | Rev actual ($M) | Rev surprise |
|---|
| YoY growth | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | +13.4% | +14.7% | +6.5% | +5.9% | +19.4% |
| Gross profit | -6.7% | +17.3% | +4.0% | -2.8% | +41.6% |
| Operating income | -42.1% | -26.1% | +122.3% | +8.4% | -339.9% |
| Net income | -25.5% | -10.8% | +124.8% | +22.3% | -301.9% |
| $B · FY ends | FY21 | FY22 | FY23 | FY24 | FY25 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 126.0 | 144.5 | 154.0 | 163.1 | 194.8 | |
| Cost of revenue | 111.8 | 127.9 | 136.7 | 146.2 | 170.9 | |
| Gross profit | 14.2 | 16.7 | 17.3 | 16.8 | 23.8 | |
| R&D expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| SG&A expense | 9.6 | 11.6 | 12.6 | 12.4 | 13.3 | |
| Operating income | 1.8 | 1.3 | 2.9 | 3.2 | -7.6 | |
| EBITDA | 3.8 | 4.1 | 5.6 | 6.2 | -5.1 | |
| D&A | 1.3 | 1.4 | 1.3 | 1.2 | 1.3 | |
| Pretax income | 1.8 | 2.0 | 3.6 | 4.3 | -6.7 | |
| Income tax | 0.5 | 0.8 | 0.9 | 1.0 | -0.1 | |
| Net income | 1.3 | 1.2 | 2.7 | 3.3 | -6.7 | |
| Diluted EPS ($) | 2.28 | 2.07 | 4.95 | 6.31 | -13.62 | |
| Diluted shares (M) | 591 | 582 | 546 | 524 | 491 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Cash & equivalents | 12.1 | 17.2 | 14.1 | 17.9 | |
| ST investments | 2.3 | 2.5 | 2.6 | 0.0 | |
| Receivables (net) | 13.3 | 15.5 | 19.7 | 18.1 | |
| Total current assets | 30.1 | 40.8 | 38.0 | 36.0 | |
| PP&E (net) | 5.0 | 2.4 | 2.4 | 2.4 | |
| Goodwill + intangibles | 25.7 | 23.7 | 23.0 | 15.4 | |
| Total assets | 76.9 | 84.6 | 82.4 | 77.7 | |
| Accounts payable | 9.3 | 16.3 | 13.0 | 20.5 | |
| Short-term debt | 0.1 | 0.1 | 0.1 | 0.2 | |
| Deferred revenue | 0.5 | 0.7 | 0.7 | 0.7 | |
| Total current liabilities | 28.5 | 36.7 | 34.3 | 21.5 | |
| Long-term debt | 17.9 | 17.7 | 18.4 | 18.0 | |
| Total liabilities | 52.6 | 58.7 | 55.9 | 57.6 | |
| Shareholders' equity | 24.2 | 26.0 | 26.5 | 20.1 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Net income | 1.2 | 2.7 | 3.3 | (6.7) | |
| D&A | 1.6 | 1.3 | 1.2 | 1.3 | |
| Stock-based compensation | 0.2 | 0.2 | 0.2 | 0.2 | |
| Working capital change | 2.2 | 3.4 | (4.5) | 0.8 | |
| Operating cash flow | 6.3 | 8.1 | 0.2 | 5.1 | |
| Capital expenditures | (1.0) | (0.8) | (0.6) | (0.8) | |
| Investing cash flow | (2.9) | (1.3) | (1.1) | 0.5 | |
| Buybacks | (3.1) | (1.6) | (3.1) | (0.5) | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt issuance / (repay) | (1.1) | 0.0 | 0.7 | (1.1) | |
| Financing cash flow | (4.2) | (1.6) | (2.4) | (1.6) | |
| Free cash flow | 5.3 | 7.3 | (0.5) | 4.3 |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| PROFITABILITY | |||||||
| ROE | 5.1% | 4.7% | 10.8% | 12.7% | -28.8% | -24% | |
| ROA | 1.8% | 1.5% | 3.3% | 4.0% | -8.3% | -6.1% | |
| ROIC | 3.8% | 2.6% | 8.8% | 8.4% | -28.9% | -12.9% | |
| Gross margin | 11.3% | 11.5% | 11.2% | 10.3% | 12.2% | 16.1% | |
| Operating margin | 1.4% | 0.9% | 1.9% | 1.9% | -3.9% | -2.8% | |
| Net margin | 1.1% | 0.8% | 1.8% | 2.0% | -3.4% | -2.6% | |
| EBITDA margin | 3.0% | 2.8% | 3.6% | 3.8% | -2.6% | -1.4% | |
| FCF margin | 2.6% | 3.6% | 4.7% | -0.3% | 2.2% | — | |
| VALUATION | |||||||
| P/E | 36.20 | 38.20 | 14.77 | 9.20 | -3.03 | -6.7 | |
| P/B | 1.82 | 1.91 | 1.54 | 1.15 | 1.01 | 1.5 | |
| P/S | 0.39 | 0.32 | 0.26 | 0.19 | 0.10 | 0.18 | |
| P/FCF | 14.80 | 8.74 | 5.50 | -62.06 | 4.68 | 3.8 | |
| EV/EBITDA | 14.36 | 12.84 | 6.97 | 5.35 | -4.42 | -9.6 | |
| EV/Revenue | 0.45 | 0.37 | 0.25 | 0.20 | 0.11 | 0.1 | |
| Earnings yield | 2.8% | 2.6% | 6.8% | 10.9% | -33.0% | -14.93% | |
| FCF yield | 6.8% | 11.4% | 18.2% | -1.6% | 21.4% | 26.25% | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| LEVERAGE & SOLVENCY | |||||||
| Current ratio | 1.11 | 1.06 | 1.11 | 1.11 | 1.68 | 1.15 | |
| Quick ratio | 1.11 | 1.06 | 1.11 | 1.11 | 1.68 | 1.15 | |
| Debt / equity | 0.85 | 0.89 | 0.73 | 0.74 | 0.94 | 0.71 | |
| Debt / assets | 28.9% | 27.8% | 22.3% | 23.6% | 24.2% | 19.4% | |
| Net debt / EBITDA | 2.02 | 1.69 | -0.14 | 0.44 | -0.19 | 2.95 | |
| Interest coverage | 3.73 | 3.95 | 5.96 | 7.06 | -8.92 | — | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| EFFICIENCY | |||||||
| Asset turnover | 1.71 | 1.86 | 1.91 | 1.95 | 2.43 | 2.33 | |
| Receivables turnover | 11.49 | 11.33 | 10.69 | 9.25 | 10.30 | 10.7 | |
| DSO (days) | 32 | 32 | 34 | 39 | 35 | 34 | |
| DPO (days) | 25 | 25 | 34 | 37 | 36 | 40 | |
| Cash conversion cycle | 7 | 7 | -0 | 3 | -0 | -6 | |
| GROWTH (YoY) | |||||||
| Revenue growth | 13.4% | 14.7% | 6.5% | 5.9% | 19.4% | — | |
| Net income growth | -25.5% | -10.8% | 124.8% | 22.3% | -301.9% | — | |
| EPS growth | -27.0% | -5.7% | 134.1% | 31.0% | -306.4% | — | |
| FCF growth | -28.9% | 59.5% | 38.0% | -106.8% | 981.8% | — | |
| PER SHARE ($) | |||||||
| EPS (diluted, TTM) | 2.28 | 2.15 | 5.03 | 6.58 | -13.59 | -10.33 | |
| Book value / share | 45.28 | 42.96 | 48.06 | 52.61 | 40.63 | 45.88 | |
| Revenue / share | 212.89 | 258.15 | 286.45 | 324.86 | 396.64 | 392.32 | |
| FCF / share | 5.57 | 9.39 | 13.49 | -0.98 | 8.80 | 18.16 | |
| Cash / share | 24.77 | 25.71 | 36.55 | 33.24 | 36.43 | 54.79 | |
| SHAREHOLDER RETURN & SCORES | |||||||
| Buyback yield | 0.6% | 6.7% | 4.1% | 10.3% | 2.4% | 0.11% | |
| Altman Z-Score | 2.47 | 2.71 | 2.65 | 2.82 | 2.84 | 2.8 | |
| Piotroski F-Score | 5 | 6 | 8 | 5 | 6 | 6/9 | |
| Beneish M-Score | -2.37 | -2.71 | -2.55 | -2.03 | -3.44 | -3.80 | |
| Model | Score | Zone | Note |
|---|---|---|---|
| Piotroski F-Score | 6 / 9 | Middling | |
| Altman Z-Score | 2.8 | Grey zone | Grey |
| Income quality | N/M | Loss-making | OCF ÷ net income not meaningful with negative earnings; OCF itself is the signal |
| Beneish M-Score | -3.80 | Non-manipulator | vs −2.22 threshold |
| DuPont Decomposition (TTM) | Value |
|---|---|
| Tax burden | 1.10 |
| Interest burden | 1.16 |
| Operating margin | -2.1% |
| Asset turnover | 2.29× |
| Financial leverage | 3.39× |
| = ROE | -20% |
| Growth Quality (live) | Value |
|---|---|
| Revenue stability | 0.99 |
| Earnings stability | 0.25 |
| Earnings persistence | 0.20 |
| Revenue CAGR 3y | 9.4% |
| EPS CAGR 3y | — |
| FCF CAGR 3y | 5.4% |
| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | Piotroski | 1-yr ret |
|---|---|---|---|---|---|---|---|
| HUM | $49.6B | 38.8 | 7% | 1.7% | +18.3% | 4/9 | +54.6% |
| CI | $79.9B | 12.5 | 15% | 2.3% | +7.7% | 8/9 | +4.5% |
| ELV | $92.9B | 19.0 | 11% | 2.9% | +6.3% | 6/9 | +23.6% |
| MOH | $10.8B | 1296.0 | -0% | 0.6% | +2.6% | 5/9 | +10.0% |
| CVS | $118.1B | 24.1 | 6% | 2.8% | +7.4% | 8/9 | — |
| OSCR | $8.3B | 18.6 | 34% | 7.4% | +42.8% | 7/9 | — |
| BIIB | $34.4B | 41.0 | 5% | 3.6% | -0.5% | 3/9 | — |
| RMD | $33.6B | 22.9 | 24% | 26.2% | +9.9% | 7/9 | — |
| Consensus estimates | Revenue mean | High / Low | EPS mean | High / Low | # EPS est. |
|---|---|---|---|---|---|
| FY2026 | $196.21B | $199.71B / $194.29B | $4.87 | $5.07 / $4.78 | 12 |
| FY2027 | $193.05B | $196.00B / $189.85B | $5.30 | $6.20 / $4.95 | 12 |
| FY2028 | $199.43B | $208.56B / $187.04B | $6.54 | $7.21 / $6.08 | 5 |
| Window | Avg Target | vs. Price | # Targets |
|---|---|---|---|
| Last Quarter | $75.57 | +9.3% | 7 |
| Last Year | $58.95 | -14.8% | 39 |
| All Time | $68.16 | -1.4% | 74 |
| Moving Average | Value | Distance | % Distance | Signal |
|---|---|---|---|---|
| SMA 20 | $64.72 | +4.44 | +6.86% | Above |
| SMA 50 | $65.39 | +3.77 | +5.77% | Above |
| SMA 200 | $54.15 | +15.01 | +27.72% | Above |
| EMA 9 | $67.65 | +1.51 | +2.23% | Above |
| EMA 21 | $66.09 | +3.07 | +4.65% | Above |
| EMA 50 | $65.10 | +4.06 | +6.24% | Above |
| EMA 200 | $57.17 | +11.99 | +20.97% | Above |
| Level | Value | Level | Value |
|---|---|---|---|
| Pivot / R1 / R2 | $70.46 / $71.06 / $71.60 | S1 / S2 | $69.92 / $69.32 |
| Bollinger (20,2) | $58.96 – $70.48 | Squeeze | Off |
| 52-wk range | $31.63 – $71.06 | Off 52-wk high | -2.7% |
| ATR (14) | $2.14 (3.1%) | Historical vol | 26.5% |
| Computed from live weekly prices | CNC | S&P 500 |
|---|---|---|
| Weekly volatility (σ, 1y) | 6.78% | 1.83% |
| Best / worst week (1y) | +27.5% / -20.1% | — |
| Max drawdown (5y, monthly) | -72.3% | — |
| 1-week VaR (95%) | -7.5% | — |
| Beta (5y) | 1.11 | 1.00 |
| Reading | CNC | Medical - Healthcare Plans n=28 | Healthcare n=5,272 | All US symbols n=70,435 |
|---|---|---|---|---|
| Overall | +24.1 | +9.1 | -24.0 | -20.5 |
| Trend | +43.0 | +39.0 | -25.6 | -21.3 |
| Momentum | +64.7 | +56.0 | -28.5 | -15.8 |
| Volume | +35.2 | +24.6 | -25.0 | -3.8 |
| Executive | Total comp | Structure |
|---|---|---|
| Michael F. Neidorff Chairman, President and | $22.0M | 88% equity+incentive |
| Cynthia J. Brinkley Executive Vice President | $4.7M | 84% equity+incentive |
| Jesse N. Hunter Executive Vice President, Pr | $4.4M | 84% equity+incentive |
| Jeffrey A. Schwaneke Executive Vice Presiden | $4.3M | 85% equity+incentive |
| Keith H. Williamson Executive Vice President | $3.0M | 78% equity+incentive |
| Pillar (live disclosure scores) | Score |
|---|---|
| Environmental | 55 |
| Social | 53 |
| Governance | 66 |
| Composite ESG | 58 |
| Filed | 8-K contents | Items |
|---|---|---|
| 2026-10-08 | Other Events | 8.01 |
| 2026-09-16 | Regulation FD | 7.01 |
| 2026-08-17 | Officer/Director Change; Regulation FD; Exhibits | 5.02,7.01,9.01 |
| 2026-07-29 | Other Events | 8.01 |
| 2026-07-28 | Earnings Release; Officer/Director Change; Regulation FD; Exhibits | 2.02,5.02,7.01,9.01 |
| 2026-06-22 | Officer/Director Change; Regulation FD; Exhibits | 5.02,7.01,9.01 |
| 2026-05-15 | Officer/Director Change; Shareholder Vote | 5.02,5.07 |
| 2026-04-28 | Earnings Release; Exhibits | 2.02,9.01 |
Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.
| Data domain | Source | Coverage for this report |
|---|---|---|
| Price & volume | market_db.historical_prices | 52 rows |
| Fundamentals | income_statements_annual | 6 rows · 2020 to 2025 |
| Reported vs consensus | fact/earnings_calendar | 24 rows · 2020-10-27 to 2026-07-28 |
| Analyst estimates | dim/forward_estimates | 3 rows · 2026-12-31 to 2028-12-31 |
| Institutional ownership (13F) | holdings_db.institutional_ownership_summary | 99 rows · 2001 to 2026 |
| Insider transactions (Form 4) | edgar/form4 | 12 rows · 2026-06-30 to 2026-10-15 |
| Proposed sales (Form 144) | edgar/form144 | 1 record |
| Beneficial ownership (13D/G) | edgar/13dg | 4 rows · 2025-11-05 to 2026-04-29 |
| Short-sale volume (FINRA) | edgar/short_volume_daily | 60 rows · 2026-07-23 to 2026-10-15 |
| Dark pool (ATS, tier 1) | edgar/darkpool_weekly | 12 rows · 2026-06-15 to 2026-08-31 |
| ETF & fund holding | etf_holdings_changelog (30d) | 1 record |
| Peer set | stock_peers_dynamic | 8 rows |
| Industry medians | industry_medians | 1 record |
| Congressional trades | congress_db (House + Senate) | 1 record |
| ESG | fact/esg_disclosures | 1 record |
Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.
Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.